DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS AT TREATMENT OF ARTERIAL HYPERTENSION: LERKAMEN
Arterial hypertension (AH) is independent risk factor of myocardial infarction, brain stroke, chronic heart failure (CHF) and hypertensive nephropathy, death from cardiovascular diseases.
Main aim of therapy of AH is maximal decreasing of risk of development of cardiovascular morbidity and mortality.
This lecture includes data about pharmacodynamics and therapeutic efficiency of dihydropyridine calcium channel blocker Lerkamen, its advantages, indications and contraindications, metabolic neutrality, organ protection.
Л.К. Каражанова, д.м.н., профессор
Государственный медицинский университет города Семей
1. OpieZ.H. Drugs for the heart 4 th ed. -Philadelphia, 1995.
2. Kaplan N.M. Clinical hypertension. 5th ed - Baltimore, 1990.
3. The sixth report of the joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda, 1997.
4. Johnston CJ. The place of diuretics in the treatment of hypertension in 1993: Can we do better? Clin'and Exper Hypertension 1993; 15 (6):1239-55.
5. Kaplan NM. Diuretics: Cornerstone of antihypertensive therapy, Amer J. Cardiol 1996;77 (6):3B-5B.
6. Madkour H., Yadallah M.M., Riveline B. et al. Ludapamide is superior to thiazide in the preservation of renal function in patients with renal insufficiency and systemic hypertension. Amer J Cardiol 1996, 77(6):23-25.
7. Achhammer J., Metz P. Low dose loop diuretics in es-sential hypertension. Experience with torasemide. Drugs 1991 ;41 (suppl 3):80-91.
8. Psaty BM, Smith MZ., Siskovick DS. et al., Health out-comes associated with antihypertensive agents. A systematic review and metaanalysis. JAMA 1997;277 (9):739-45.
9. Warram JH, Zaffel ZMB, Valsania P. et al. Excess mortality associated with diuretic therapy in diabetes mellitus. Arch Intern Med 1991; 151 (7):1350-6.
10.Curb JD, Pressel Sz, Cutler JA. et al. Effect of diuret-ic-based antihypertensive treatment on cardiovascular dis-ease risk in older diabetic patients with isolated systolic hyper-tension. JAMA 199б;276 (23): 1886-92.
11. Yottdiener JS, Reda DJ, Massic BM. et al. Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension. Circulation 1997;95 (8):2007-14.
12. Neaton JD, Yrimm RH, Jr, Prineas RJ et al. Treatment of mild hypertension study. JAMA 1993;270(6):713-24.
13. Materson BJ, Reda DJ, Cushman WC. et al. Department of Veterans Affairs single-clung therapy of hy-pertension study. Amer J Hypertens 1995;8 (2):189-92.
Number of Views: 256
Category of articles:
Lectures
Bibliography link
Л.К. Каражанова АНТАГОНИСТЫ КАЛЬЦИЯ ДИГИДРОПИРИДИНОВОГО РЯДА В ЛЕЧЕНИИ АРТЕРИАЛЬНОЙ ГИПЕРТОНИИ: В ФОКУСЕ ЛЕРКАМЕН //НАУКА И ЗДРАВООХРАНЕНИЕ 2012.№ 2. С. 18-24 L.K. Karazhanova DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS AT TREATMENT OF ARTERIAL HYPERTENSION: LERKAMEN // NAUKA I RAVOOKHRANENIE. 2012.№ 2. С. 18-24 Л.Қ. Қаражанова АРТЕРИАЛДЫ ГИПЕРТОНИЯНЫҢ ЕМІНДЕ ДИГИДРОПИРИДИН ТУЫНДЫСЫ КАЛЬЦИЙ АНТАГОНИСТЕРІ: ФОКУСТА ЛЕРКАМЕН // ҒЫЛЫМ ЖӘНЕ ДЕНСАУЛЫҚ САҚТАУ. 2012.№ 2. С. 18-24Related publications:
PAIN AND INCREASED MUSCLE TONE AFTER A STROKE AS REDUCTION FACTORS FOR REHABILITATION POTENTIAL. A MULTIDISCIPLINARY APPROACH TO THE MANAGEMENT OF PATIENTS
FEATURES OF VARIOUS NEUROLOGICAL SYSTEMS DYSFUNCTION OF VASCULAR DISEASES OF THE BRAIN
DIAGNOSIS AND TREATMENT OF CHRONIC HEART FAILURE (CHF)
CALCIUM CHANNELS BLOCKERS - A ROLE IN MODERN THERAPY OF CARDIOVASCULAR DISEASES: IN FOCUS – DILTIAZEM
DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS AT TREATMENT OF ARTERIAL HYPERTENSION: LERKAMEN